Duloxetine hydrochloride is a well-established serotonin-norepinephrine reuptake inhibitor (SNRI), built around a naphthalene ring system linked to a thiophene group. It's one of the more versatile APIs in the CNS category because its approved uses span both mental health and chronic pain management.
Mechanism of action
Duloxetine works by inhibiting the reuptake of serotonin and norepinephrine at the synapse, increasing the availability of both neurotransmitters. This dual action is what separates SNRIs from single-target SSRIs and underlies duloxetine's use in both mood disorders and neuropathic pain conditions.
Common therapeutic applications
- Major depressive disorder (MDD)
- Generalized anxiety disorder (GAD)
- Diabetic peripheral neuropathic pain
- Fibromyalgia
- Chronic musculoskeletal pain, including osteoarthritis and chronic low back pain
Manufacturing and formulation notes
Duloxetine base is acid-labile, which is why finished products are almost always formulated as enteric-coated pellets inside a capsule rather than a standard tablet — the coating protects the API from gastric degradation before it reaches the small intestine for absorption. Formulators sourcing the API should confirm particle size distribution and polymorphic form up front, since both affect pellet-coating performance and dissolution behavior downstream.
Sourcing through NexaImpex
NexaImpex works with WHO-GMP compliant manufacturing partners across India's pharmaceutical belt to supply duloxetine hydrochloride API at both bulk and sample scale, with full documentation (COA, MSDS, TDS, and DMF/CEP references) prepared for import into regulated markets. Packaging and logistics are handled to preserve API integrity across cold-chain and standard shipment routes alike.
If you're formulating a duloxetine product and need a reliable, documented supply chain, our team can share current specifications and lead times.
